Glenmark Pharmaceuticals announces resignation of company secretary & compliance officer
With effect from 31 October 2016
Glenmark Pharmaceuticals announced that the Board of Directors of the Company at its Meeting held on 27 October 2016 noted and approved the resignation of Sanjay Kumar Chowdhary, Company Secretary & Compliance Officer with effect from 31 October 2016.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content